Intranet
  • Innovations
  • About
  • Partners
  • Resources
  • Educational
  • News
  • Innovations
  • About
  • Partners
  • Resources
  • Educational
  • News

InterLynk landed on Twitter and LinkedIn - Follow and Like us!

19 Nov 2021

Follow InterLynk on Social Media for the latest information on our research on the development of scaffolds for multi-tissue regeneration. 

Follow us here on TWITTER.

Follow us here on LINKEDIN. 

Share

Recommended articles

After Four Years of Research, InterLynk Project Delivers New Pathways for Multi-Tissue Regeneration
10 Oct 2025

European researchers have achieved a milestone in regenerative medicine with an integrated platform that combines advanced biomaterials, modelling, and 3D bioprinting to create personalized scaffolds for multi-tissue regeneration. These scaffolds are designed to support the body’s own repair processes in unprecedented ways, paving the way for future therapies beyond current solutions.

Jamming for Healing: How Blood-Derived Proteins Are Shaping the Future of Bioprinting
2 Jul 2025

A collaborative team led by InterLynk scientists has engineered a printable, cell-compatible bioink using human platelet lysates, advancing the potential of personalized regenerative medicine.

The Surgeon’s Hands versus the Researcher’s Vision: Aligning Innovation with Clinical Practice
25 Jun 2025

InterLynk scientists embrace co-creation with clinicians to guide the development of regenerative scaffolds.

PROJECT CONTACTS
João Mano (Project Coordinator)

jmano@ua.pt 

General enquiries

secretariat@interlynk-h2020.eu 

FOLLOW US

InterLynk-H2020

European Union Flag

Interlynk has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 953169. 

The product information you can find on this website is intended only for scientific researchers. Generic information related to medical conditions and their treatment is provided for informational purposes only and is not a substitute for qualified advice from a doctor or health care professional. Please do consult your professional healthcare provider for medical advice in case you are a patient or carer of a patient. 

Implemented by Promoscience